QuidelOrtho paid its 5 named executives $23.9M in total in FY2025 (Jan). CEO Brian J. Blaser was paid $11.3M of that.
Pay$100 in the stock at the end of FY23 → $51
Pay of each named executive
Brian J. BlaserPresident and CEO
| FY2025 (Jan) | |||||||
| FY2024 (Jan) |
2 years
| FY2025 (Jan) | |||||||
| FY2024 (Jan) | |||||||
| FY2023 (Jan) | |||||||
| FY2022 (Jan) | Not disclosed |
4 years
Michelle A. HodgesFormer CLO
| FY2025 (Jan) | |||||||
| FY2024 (Jan) | |||||||
| FY2023 (Jan) | Not disclosed | ||||||
| FY2022 (Jan) | Not disclosed |
4 years
| FY2025 (Jan) | |||||||
| FY2024 (Jan) |
2 years
Jonathan P. SiegristEVP of R&D and CTO
| FY2025 (Jan) | |||||||
| FY2024 (Jan) |
2 years
CEO pay against the pay peers
In FY2025 (Jan), the median CEO pay of the 9 peers with pay on file was $10.6M. The CEO of QuidelOrtho was paid $11.3M, 7% above the median.
- 1Evolent Health
- 2RadNet
- 3QuidelOrthoThis company
- 4Teladoc Health
- 5Sotera Health
- 6Envista Holdings
- 7Dentsply Sirona
- 8CONMED
- 9Teleflex
- 10Bruker
- 11Bio-Rad Laboratories, Inc.Not disclosed
- 12EnovisNot disclosed
- 13Exact Sciences CorporationNot disclosed
- 14Fortrea Holdings Inc.Not disclosed
- 15ICU Medical, Inc.Not disclosed
- 16Integer HoldingsNot disclosed
- 17Integra LifeSciences Holdings CorporationNot disclosed
- 18Masimo CorporationNot disclosed
- 19OmnicellNot disclosed
- 20Veradigm Inc.Not disclosed
'/%3e%3cpath%20class='cls-4'%20d='M219.5,105.33a59.84,59.84,0,0,1,19.7-3.61c10.73,0,17.66,4,17.66,16.28v25.89H245.67V118.74c0-4.63-2.49-7-7.3-7a26.29,26.29,0,0,0-7.77,1.2v31H219.5Z'%20transform='translate(-51.41%20-51.41)'/%3e%3cpath%20class='cls-4'%20d='M267.83,102.65V92.47h11.09v10.18h11.75v9.24H278.92v16.56c0,4.71,2.22,6.19,5.55,6.19a14.06,14.06,0,0,0,7.59-2.31V142.5a22.35,22.35,0,0,1-10.64,2.31c-7.12,0-13.59-3.42-13.59-13.4V102.65Z'%20transform='translate(-51.41%20-51.41)'/%3e%3cpath%20class='cls-4'%20d='M309.75,126.32v.18c.84,5.83,6.57,8.79,12.12,8.79a25.58,25.58,0,0,0,13.78-3.7V141c-3.8,2.68-9.34,3.79-14.89,3.79-13.41,0-21.83-8.23-21.83-21.08,0-13.59,8.6-22,20.16-22,12.86,0,17.85,8.51,17.85,19.42v5.18Zm16.83-6.66c-.09-5.09-2.49-8.78-7.76-8.78-4.81,0-8,3.42-9,8.78Z'%20transform='translate(-51.41%20-51.41)'/%3e%3cpath%20class='cls-4'%20d='M372.87,142.13a18.65,18.65,0,0,1-7.58,1.39c-12.48,0-21.17-7.21-21.17-20.72,0-13.13,8.78-21.08,23.21-21.08a44.94,44.94,0,0,1,16.73,3.15v38.37c0,14.15-11.37,18.22-20.71,18.22a32.74,32.74,0,0,1-14.15-3.05V148.05c5,2.87,9.06,4.07,14.15,4.07,5.36,0,9.52-2.87,9.52-9.16Zm0-29.87a19.47,19.47,0,0,0-5.54-.83c-7.4,0-11.93,3.79-11.93,11.37,0,7.13,4.44,11.38,11.19,11.38a18.71,18.71,0,0,0,6.28-1.2Z'%20transform='translate(-51.41%20-51.41)'/%3e%3cpath%20class='cls-4'%20d='M403.48,126.32v.18c.84,5.83,6.57,8.79,12.12,8.79a25.58,25.58,0,0,0,13.78-3.7V141c-3.8,2.68-9.34,3.79-14.89,3.79-13.41,0-21.83-8.23-21.83-21.08,0-13.59,8.6-22,20.16-22,12.86,0,17.85,8.51,17.85,19.42v5.18Zm16.83-6.66c-.09-5.09-2.49-8.78-7.76-8.78-4.81,0-8,3.42-9,8.78Z'%20transform='translate(-51.41%20-51.41)'/%3e%3cpath%20class='cls-4'%20d='M451.2,143.89H440.1v-38.1A36.05,36.05,0,0,1,456.56,102a29.73,29.73,0,0,1,8.6,1.11v10.73a21.86,21.86,0,0,0-8.32-1.39,18.67,18.67,0,0,0-5.64.92Z'%20transform='translate(-51.41%20-51.41)'/%3e%3cpath%20class='cls-4'%20d='M480.91,92.23a7.79,7.79,0,1,1-7.72,7.79A7.57,7.57,0,0,1,480.91,92.23Zm0,14.64a6.85,6.85,0,1,0-6.7-6.85A6.53,6.53,0,0,0,480.91,106.87Zm-1.32-2.46h-1.4V95.56a13.65,13.65,0,0,1,2.24-.21c2.28,0,3.62,1,3.62,3a2.73,2.73,0,0,1-1.77,2.58l2.69,3.48h-1.68l-2.41-3.17h-1.29Zm0-4.36h1c1.27,0,2-.54,2-1.7s-.68-1.7-2.13-1.7a7.52,7.52,0,0,0-.86,0Z'%20transform='translate(-51.41%20-51.41)'/%3e%3c/svg%3e)
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.